The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1

No abstract is available for this paper.

• Publication year

  2017

• Venue

  EMBO Reports

• Publication date

  2017-06-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.15252/embr.201643370PMID 28652379PMCID PMC5538427
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Western Blot

  2019cited by this paper
• The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1

  2017cited by this paper
• VEGF121 and VEGF165 differentially promote vessel maturation and tumor growth in mice and humans

  2016cited by this paper
• The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression

  2016cited by this paper
• ID4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA1 function in basal-like breast cancer.

  2016cited by this paper
• Differentiation of mammary tumors and reduction in metastasis upon Malat1 lncRNA loss

  2016cited by this paper
• Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple‐negative breast cancer, adversely affects survival

  2016cited by this paper
• ID 4 controls luminal lineage commitment in normal mammary epithelium and inhibits BRCA 1 function in basal-like breast cancer

  2016cited by this paper
• Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer

  2016cited by this paper
• Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer

  2016cited by this paper
• Aerobic glycolysis tunes YAP/TAZ transcriptional activity

  2015cited by this paper
• Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.

  2015cited by this paper
• ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype

  2015cited by this paper
• TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance

  2014cited by this paper
• Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

  2014cited by this paper
• RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites.

  2014cited by this paper
• Emerging Functions of SRSF1, Splicing Factor and Oncoprotein, in RNA Metabolism and Cancer

  2014cited by this paper
• Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB

  2013cited by this paper
• Comprehensive molecular portraits of human breast tumours

  2013cited by this paper
• MALAT1 — a paradigm for long noncoding RNA function in cancer

  2013cited by this paper
• The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes

  2012cited by this paper
• Comprehensive molecular portraits of human breast tumors

  2012cited by this paper
• Id4 protein is highly expressed in triple-negative breast carcinomas: possible implications for BRCA1 downregulation

  2012cited by this paper
• Psip1/Ledgf p52 Binds Methylated Histone H3K36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing

  2012cited by this paper
• Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles.

  2012cited by this paper
• A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails.

  2012cited by this paper
• Regulating the regulators: Serine/arginine‐rich proteins under scrutiny

  2012cited by this paper
• Explorer Psip 1 / Ledgf p 52 Binds Methylated Histone H 3 K 36 and Splicing Factors and Contributes to the Regulation of Alternative Splicing

  2012cited by this paper
• Malat1 is not an essential component of nuclear speckles in mice.

  2012cited by this paper
• The rebel angel: mutant p53 as the driving oncogene in breast cancer

  2012cited by this paper
• The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult.

  2012cited by this paper
• The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

  2012cited by this paper
• The role of VEGF165b in pathophysiology

  2012cited by this paper
• Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions.

  2011cited by this paper
• Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists

  2011cited by this paper
• ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs.

  2011cited by this paper
• Nuclear speckles.

  2011cited by this paper
• RNA splicing control

  2011cited by this paper
• WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.

  2011cited by this paper
• The role of mutant p53 in human cancer

  2011cited by this paper
• THE SPLICING FACTOR SRSF1 REGULATES APOPTOSIS AND PROLIFERATION TO PROMOTE MAMMARY EPITHELIAL CELL TRANSFORMATION

  2011cited by this paper
• Balance of pro‐ versus anti‐angiogenic splice isoforms of vascular endothelial growth factor as a regulator of neuroblastoma growth

  2010cited by this paper
• The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation.

  2010influential reference
• Mutant p53 gain-of-function in cancer.

  2010cited by this paper
• A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression

  2010cited by this paper
• ID4: a new player in the cancer arena

  2010cited by this paper
• Regulation of Vascular Endothelial Growth Factor (VEGF) Splicing from Pro-angiogenic to Anti-angiogenic Isoforms

  2009cited by this paper
• Biased chromatin signatures around polyadenylation sites and exons.

  2009cited by this paper
• Splicing factor SFRS1 recognizes a functionally diverse landscape of RNA transcripts.

  2009cited by this paper
• Supervised risk predictor of breast cancer based on intrinsic subtypes.

  2009cited by this paper
• The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis

  2009influential reference
• Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors

  2008cited by this paper
• Differential chromatin marking of introns and expressed exons by H3K36me3

  2008cited by this paper
• VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy

  2008cited by this paper
• 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA.

  2008cited by this paper
• The endogenous anti-angiogenic VEGF isoform, VEGF165b inhibits human tumour growth in mice

  2008cited by this paper
• VEGF-A splicing: the key to anti-angiogenic therapeutics?

  2008cited by this paper
• A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains

  2007cited by this paper
• The gene encoding the splicing factor SF2/ASF is a proto-oncogene

  2007cited by this paper
• Impaired glomerular maturation and lack of VEGF165b in Denys-Drash syndrome.

  2007cited by this paper
• A VEGF-A splice variant defective for heparan sulfate and neuropilin-1 binding shows attenuated signaling through VEGFR-2

  2006cited by this paper
• The role of VEGF receptors in angiogenesis; complex partnerships

  2006cited by this paper
• Gain of function of mutant p53: the mutant p53/NF-Y protein complex reveals an aberrant transcriptional mechanism of cell cycle regulation.

  2006cited by this paper
• Diabetic retinopathy is associated with a switch in splicing from anti- to pro-angiogenic isoforms of vascular endothelial growth factor

  2005cited by this paper
• Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation.

  2005cited by this paper
• Sorting points into neighborhoods (SPIN): data analysis and visualization by ordering distance matrices

  2005cited by this paper
• VEGF165b, an Inhibitory Vascular Endothelial Growth Factor Splice Variant

  2004cited by this paper
• About the authors

  2004cited by this paper
• Automatic and quantitative measurement of protein-protein colocalization in live cells.

  2004cited by this paper
• A Syntaxin 1, Gαo, and N-Type Calcium Channel Complex at a Presynaptic Nerve Terminal: Analysis by Quantitative Immunocolocalization

  2004cited by this paper
• MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer

  2003cited by this paper
• VEGF 165 b , an Inhibitory Splice Variant of Vascular Endothelial Growth Factor , Is Down-Regulated in Renal Cell Carcinoma 1

  2002cited by this paper
• VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.

  2002cited by this paper
• Differential expression of γ‐aminobutyric acid type B receptor‐1a and ‐1b mRNA variants in GABA and non‐GABAergic neurons of the rat brain

  2000cited by this paper
• Serine Phosphorylation of SR Proteins Is Required for Their Recruitment to Sites of Transcription In Vivo

  1998cited by this paper
• Measurement of co‐localization of objects in dual‐colour confocal images

  1993cited by this paper
• Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy.

  1992cited by this paper

• Alternative splicing: from tumorigenesis to neoantigen-mediated cancer immunotherapy

  2025cites this paper
• The Evolving Role of Alternative Splicing in Cancer Stem Cell Plasticity: From Mechanisms To Clinical Opportunities.

  2025cites this paper
• The Role of Non-Coding Regions in Breast Cancer: From Gene Regulation to Therapeutic Implications

  2025cites this paper
• The role of long non‐coding RNAs in lung cancer metastasis: Molecular mechanisms, pathogenesis and clinical implications

  2025cites this paper
• MALAT1 overexpression contributes to choriocarcinoma by binding with RBM10 and promoting p53 degradation.

  2025cites this paper
• MARBP-lncRNA Complexes Alter Gene Function Through Modulation of Epigenetic Landscape

  2025cites this paper
• Targeting NSCLC drug resistance: Systems biology insights into the MALAT1/miR-145-5p axis and Wip1 in regulating ferroptosis and apoptosis.

  2025cites this paper
• The lncRNA SENCR knockdown alleviates vascular calcification via miR-4731-5p by suppressing endoplasmic reticulum stress

  2025cites this paper
• The Critical Role of Inhibitor of Differentiation 4 in Breast Cancer: From Mammary Gland Development to Tumor Progression

  2025cites this paper
• p53: A player in the tumor microenvironment

  2025cites this paper
• lncRNAs: the unexpected link between protein synthesis and cancer adaptation

  2025cites this paper
• Long noncoding RNA MALAT-1: A versatile regulator in cancer progression, metastasis, immunity, and therapeutic resistance

  2024cites this paper
• Research Progress on N6-Methyladenosine Modification in Angiogenesis, Vasculogenic Mimicry, and Therapeutic Implications in Breast Cancer.

  2024cites this paper
• Polo-like kinase 2 targeting as novel strategy to sensitize mutant p53-expressing tumor cells to anticancer treatments

  2024cites this paper
• LncRNA CARMN m6A demethylation by ALKBH5 inhibits mutant p53‐driven tumour progression through miR‐5683/FGF2

  2024cites this paper
• Differential expression of oncogenic lncRNAs NEAT1 and MALAT1 in 2D monolayer vs. 3D tumoroid culture and its implications in cancer progression

  2024cites this paper
• Epigenetics and alternative splicing in cancer: old enemies, new perspectives.

  2024cites this paper
• Roles of lncRNAs related to the p53 network in breast cancer progression

  2024cites this paper
• Aberrant alternative splicing in cancer: Splicing events and their regulatory mechanisms (Review).

  2024cites this paper
• The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer

  2024cites this paper
• SR proteins in cancer: function, regulation, and small inhibitor

  2024cites this paper
• Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy

  2024cites this paper
• ID4-dependent secretion of VEGFA enhances the invasion capability of breast cancer cells and activates YAP/TAZ via integrin β3-VEGFR2 interaction

  2024cites this paper
• How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors

  2023cites this paper
• The nexus of long noncoding RNAs, splicing factors, alternative splicing and their modulations

  2023cites this paper
• Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment

  2023cites this paper
• p53-regulated lncRNAs in cancers: from proliferation and metastasis to therapy

  2023cites this paper
• p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression.

  2023cites this paper
• Identification of G-quadruplex structures in MALAT1 lncRNA that interact with nucleolin and nucleophosmin

  2023cites this paper
• The MALAT1-breast cancer interplay: insights and implications

  2023cites this paper
• Mutant P53 in the formation and progression of the tumor microenvironment: Friend or foe.

  2023cites this paper
• Long Non-coding RNA MALAT1: A Key Player in Liver Diseases

  2022cites this paper
• Competing Endogenous RNA (ceRNA) Networks and Splicing Switches in Cervical Cancer: HPV Oncogenesis, Clinical Significance and Therapeutic Opportunities

  2022cites this paper
• p53: From Fundamental Biology to Clinical Applications in Cancer

  2022cites this paper
• Li–Fraumeni Syndrome: Mutation of TP53 Is a Biomarker of Hereditary Predisposition to Tumor: New Insights and Advances in the Treatment

  2022cites this paper
• MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer

  2022cites this paper
• Non‐coding RNA regulatory networks in post‐transcriptional regulation of VEGFA in cancer

  2022cites this paper
• Long Non-Coding RNAs in the Cell Fate Determination of Neoplastic Thymic Epithelial Cells

  2022cites this paper
• Secreted Non-Coding RNAs: Functional Impact on the Tumor Microenvironment and Clinical Relevance in Triple-Negative Breast Cancer

  2022cites this paper
• Long Noncoding RNA PVT1 Promotes Stemness and Temozolomide Resistance through miR-365/ELF4/SOX2 Axis in Glioma

  2021cites this paper
• Interplay between p53 and non-coding RNAs in the regulation of EMT in breast cancer

  2021cites this paper
• Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53

  2021cites this paper
• LINC01116 facilitates colorectal cancer cell proliferation and angiogenesis through targeting EZH2-regulated TPM1

  2021cites this paper
• Mutant p53 Gain-of-Function: Role in Cancer Development, Progression, and Therapeutic Approaches

  2021cites this paper
• The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer

  2021cites this paper
• Critical regulatory levels in tumor differentiation: Signaling pathways, epigenetics and non‐coding transcripts

  2021cites this paper
• LncRNA LINC00525 suppresses p21 expression via mRNA decay and triplex‐mediated changes in chromatin structure in lung adenocarcinoma

  2021cites this paper
• METTL3-dependent MALAT1 delocalization drives c-Myc induction in thymic epithelial tumors

  2021cites this paper
• The Role of p53 in Progression of Cutaneous Squamous Cell Carcinoma

  2021cites this paper
• Targeting mutant p53 for cancer therapy: direct and indirect strategies

  2021cites this paper
• Interactions between long non-coding RNAs and RNA-binding proteins in cancer

  2021cites this paper
• Long non-coding RNAs are involved in alternative splicing and promote cancer progression

  2021cites this paper
• Alternative splicing modulation mediated by G-quadruplex structures in MALAT1 lncRNA

  2021cites this paper
• The role of alternative splicing in human cancer progression.

  2021cites this paper
• Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma

  2020cites this paper
• Multifaceted roles of long non-coding RNAs in triple-negative breast cancer: biology and clinical applications.

  2020cites this paper
• LINC00511 promotes lung squamous cell carcinoma proliferation and migration via inhibiting miR-150-5p and activating TADA1

  2020cites this paper
• Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

  2020cites this paper
• Gain-of-function mutant p53 in cancer progression and therapy

  2020cites this paper
• A Driver Never Works Alone—Interplay Networks of Mutant p53, MYC, RAS, and Other Universal Oncogenic Drivers in Human Cancer

  2020cites this paper
• Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

  2020cites this paper
• Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer

  2020cites this paper
• Interleukin-1α associates with the tumor suppressor p53 following DNA damage

  2020cites this paper
• The Impact of Mutant p53 in the Non-Coding RNA World

  2020influential citation
• The network of non-coding RNAs and their molecular targets in breast cancer

  2020cites this paper
• p53’s Extended Reach: The Mutant p53 Secretome

  2020cites this paper
• Paracrine Signaling from Breast Cancer Cells Causes Activation of ID4 Expression in Tumor-Associated Macrophages

  2020cites this paper
• Debunking the Myth of the Endogenous Antiangiogenic Vegfaxxxb Transcripts.

  2020cites this paper
• Mutant p53 on the Path to Metastasis.

  2020cites this paper
• Emerging Roles of lncRNAs in the Formation and Progression of Colorectal Cancer

  2020cites this paper
• Adaptor proteins in long noncoding RNA biology.

  2020cites this paper
• Hypoxia preconditioning promotes bone marrow mesenchymal stem cells survival and vascularization through the activation of HIF-1α/MALAT1/VEGFA pathway

  2020cites this paper
• Hypoxia preconditioning promotes mesenchymal stem cells survival and vascularization through the activation of MALAT1/miR-195/VEGFA axis

  2020cites this paper
• BMP9 prevents induction of osteopontin in JNK-inactivated osteoblasts via Hey1-Id4 interaction.

  2019cites this paper
• MALAT1 long non-coding RNA and breast cancer

  2019cites this paper
• Identification and characterization of differentially expressed genes in Type 2 Diabetes using in silico approach

  2019cites this paper
• P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs

  2019cites this paper
• The Role of MALAT 1 in Cancer

  2019cites this paper
• A lncRNA coordinates with Ezh2 to inhibit HIF-1α transcription and suppress cancer cell adaption to hypoxia

  2019cites this paper
• Metastasis Associated Lung Adenocarcinoma Transcript 1: An update on expression pattern and functions in carcinogenesis.

  2019cites this paper
• Long noncoding RNA Malat1 regulates differential activation of macrophages and response to lung injury.

  2019cites this paper
• MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches

  2018cites this paper
• Insight into the regulatory mechanism of VEGFA isoforms in p53 mutant breast cancer: can it be substantiated with solely in vitro studies?

  2018cites this paper
• A novel role for the HLH protein Inhibitor of Differentiation 4 (ID4) in the DNA damage response in basal-like breast cancer

  2018cites this paper
• Long non-coding RNA SENCR alleviates the inhibitory effects of rapamycin on human umbilical vein endothelial cells

  2018cites this paper
• New therapeutic strategies to treat human cancers expressing mutant p53 proteins

  2018cites this paper
• Zebrafish as experimental model to establish the contribution of mutant p53 and ID4 to breast cancer angiogenesis in vivo.

  2018cites this paper
• MALAT1: a potential biomarker in cancer

  2018cites this paper
• Assessment of functional variants and expression of long noncoding RNAs in vitamin D receptor signaling in breast cancer

  2018cites this paper
• RBPs Play Important Roles in Vascular Endothelial Dysfunction Under Diabetic Conditions

  2018cites this paper
• Chaperoning the guardian of the genome. The two-faced role of molecular chaperones in p53 tumor suppressor action.

  2018cites this paper
• Functions and regulatory mechanisms of metastasis‐associated lung adenocarcinoma transcript 1

  2018cites this paper
• Expression of ID4 protein in breast cancer cells induces reprogramming of tumour-associated macrophages

  2018cites this paper
• Shift in VEGFA isoform balance towards more angiogenic variants is associated with tumor stage and differentiation of human hepatocellular carcinoma

  2018cites this paper
• The mutant p53‐ID4 complex controls VEGFA isoforms by recruiting lncRNA MALAT1

  2017cites this paper
• Elucidating the Role of Host Long Non-Coding RNA during Viral Infection: Challenges and Paths Forward

  2017cites this paper
• Newcastle disease virus Tabanan-1/ARP/2017 suppresses Ki67 and VEGF expression in rat mammary carcinoma models

  year unknowncites this paper